Shalina Healthcare, a leading pharmaceutical company, has launched its Consumer Division, marking a strategic move into the Over the Counter (OTC) and consumer healthcare market and bringing a range of renowned global brands to the Kenyan market.
Among the exciting additions to Shalina Healthcare’s portfolio are Germol, a personal hygiene brand with a strong presence in Sub-Saharan Africa, and Monalisa, a line of body lotions and creams specifically formulated for African skin.
Shalina Healthcare Ltd, Vice President & Business Head for East Africa, Vikas Khandelwal, says: “Our continued growth and expansion in Kenya are testaments to our dedication to improving healthcare outcomes and creating job opportunities in the region. We remain focused on our founding principles of quality, affordability, and availability as we strive to make a meaningful impact on healthcare across Africa.”
Shalina Healthcare entered into the Kenyan market in 2018 through the acquisition of Pharmaceutical Manufacturing Company (PMC). This move enabled the company to introduce global brands in key therapeutic areas, including dermatology and pain management.
The subsequent acquisition of Orange Pharma Limited in 2022 elevated Shalina Healthcare into the top 5 pharmaceutical companies in Kenya, enhancing its capability to meet the diverse healthcare needs of Kenyans.
Today’s launch also celebrates the acquisition of beloved household names Kaluma, Sonamoja, and Sonadol, further cementing Shalina’s commitment to accessible, high-quality healthcare. From its headquarters at Shalina House in Babadogo, Thika Road, the company’s Kenyan operations now employ over 200 individuals, supporting a nationwide sales and marketing network.